Overview

Ipratropium Spray for Drooling Saliva in Parkinson's Disease

Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
A phase II double blind clinical trial investigating the effects of ipratropium spray versus placebo spray in patients with Parkinson's disease.
Phase:
Phase 2
Details
Lead Sponsor:
University Health Network, Toronto
Collaborator:
Parkinson's Disease Foundation
Treatments:
Bromides
Ipratropium